Chronic Lymphocytic Leukemia Progression and Recurrence
Relapsed vs. refractory CLL: Understanding why your treatment path is changing
In clinical settings, you’ll often hear your care team use the shorthand R/R, standing for relapsed/refractory. This term covers patients with relapsed/refractory chronic lymphocytic leukemia (CLL) who either saw their disease return after a period of remission or whose CLL never adequately responded to treatment in the first place. The term “relapsed/refractory” is frequently used…
What does “double-refractory” in CLL mean for patients?
When standard treatments for chronic lymphocytic leukemia (CLL) stop working, patients face important decisions about what comes next. In our recent webinar, Stanford University’s Dr. Bita Fakhri highlights how emerging approaches, from next-generation BTK inhibitors to CAR T-cell therapy, are offering new hope for this population. Watch the full webinar. The following questions and responses…
Treatment options and clinical trials for CLL
Treatment options for chronic lymphocytic leukemia (CLL) are highly individualized. Your care team considers several key elements when designing your treatment plan, and clinical scientist and CLL expert Dr. Bita Fakhri highlights three of the most important: the characteristics of the leukemia itself, the patient’s overall health and preferences, and the potential risks and benefits…
See treatment options, manage symptoms, and stay informed--all in the app
View treatment options and trials personalized to your diagnosis --all in one place.
Cancer care guidance for every step of your journey
Get treatment options, clinical trials, and support tailored to your diagnosis--all in one place.
A guide on chronic lymphocytic leukemia clinical trials
After a chronic lymphocytic leukemia (CLL) diagnosis, you may hear about treatment options including watchful waiting, chemotherapy, targeted therapy, or immunotherapy. Asking your care team about clinical trials may provide additional ways to explore innovative therapies and treatment strategies. In CLL, clinical trials are driving advances in targeted therapy, combination regimens, and precision medicine approaches…
Own your treatment journey—view your plan and get support in the Outcomes4Me app
- Personalized cancer care guided by trusted NCCN Guidelines®
- Track symptoms, medications, and side effects in real time
- Discover clinical trials and genetic testing matched to your diagnosis
- Join communities for your cancer type and build meaningful connections
Take control of your cancer care- start with Outcomes4Me
Get started with Outcomes4Me